Patents Represented by Attorney Arthur R. Whale
  • Patent number: 4525587
    Abstract: (6R,7R)-7-[(Z)-2-(2-triphenylmethylaminothiazol-4-yl)-2-(2-tert.-butoxycarb onylprop-2-oxyimino)acetamido]-3-(1-pyridiniummethyl)ceph-3-em-4-carboxylat e is isolated by formation of N,N-dimethylacetamide solvates.
    Type: Grant
    Filed: February 3, 1984
    Date of Patent: June 25, 1985
    Assignee: Eli Lilly and Company
    Inventors: Ta-Sen Chou, Perry C. Heath
  • Patent number: 4525304
    Abstract: Compounds of the formula ##STR1## in which Y is hydrogen or hydroxyl, useful as intermediates in the production of antibiotics, are prepared by reacting a sulfinic acid of the formula ##STR2## with an oxidizing agent.
    Type: Grant
    Filed: November 16, 1982
    Date of Patent: June 25, 1985
    Assignee: Eli Lilly and Company
    Inventors: David A. Hall, Wayne A. Spitzer
  • Patent number: 4524135
    Abstract: A-21978C cyclic peptides of the formula ##STR1## wherein R is selected from the group consisting of hydrogen, an amino-protecting group , 8-methyldecanoyl, 10-methylundecanoyl, 10-methyldodecanoyl, the specific C.sub.10 -alkanoyl group of A-21978C factor C.sub.0 and the specific C.sub.12 -alkanoyl groups of A-21978C factors C.sub.4 and C.sub.5 ; R.sup.1 and R.sup.2 are, independently, hydrogen or an amino-protecting group, and salts thereof, are prepared by enzymatic deacylation of an antibiotic selected from A-21978C complex, A-21978C factors C.sub.0, C.sub.1, C.sub.2, C.sub.3, C.sub.4 and C.sub.5 and blocked A-21978C complex and factors C.sub.0, C.sub.1, C.sub.2, C.sub.3, C.sub.4 and C.sub.5, using an enzyme produced by the Actinoplanaceae, preferably by Actinoplanes utahensis. The A-21978C cyclic peptides and salts thereof are useful intermediates to prepare new semi-synthetic antibacterial agents.
    Type: Grant
    Filed: August 3, 1984
    Date of Patent: June 18, 1985
    Assignee: Eli Lilly and Company
    Inventors: Bernard J. Abbott, Manuel Debono, David S. Fukuda
  • Patent number: 4522750
    Abstract: There is provided by this invention cell-targeting cytotoxic compositions comprising transferrin covalently coupled to vinca alkaloid.
    Type: Grant
    Filed: February 21, 1984
    Date of Patent: June 11, 1985
    Assignee: Eli Lilly and Company
    Inventors: Edwin W. Ades, George J. Cullinan
  • Patent number: 4522919
    Abstract: Improved bioconverting strain of Streptomyces thermotolerans useful in preparing tylosin esters and new antibacterial macrocin or lactenocin ester derivatives of the formula: ##STR1## wherein R is formyl or hydroxymethyl; R.sup.1 is hydrogen, acetyl or propionyl; R.sup.2 is hydrogen or ##STR2## and R.sup.3 is hydrogen, acetyl, propionyl, n-butyryl or isovaleryl; provided that one of R.sup.1 or R.sup.3 must be other than hydrogen.
    Type: Grant
    Filed: March 3, 1983
    Date of Patent: June 11, 1985
    Assignee: Eli Lilly and Company
    Inventors: Barbara B. Shreve, Jan R. Turner
  • Patent number: 4522758
    Abstract: 2-Fluoro-17.beta.-estradiol is synthesized by mercurating a 17.beta.-estradiol diacylate or dietherate at C-2, replacing the mercury group with fluorine and then cleaving the acyl or ether protecting groups.
    Type: Grant
    Filed: December 22, 1983
    Date of Patent: June 11, 1985
    Assignee: Eli Lilly and Company
    Inventors: John S. Ward, C. David Jones
  • Patent number: 4521421
    Abstract: Sexual dysfunction in mammals is treated with a trans-(.+-.)- or trans-(-)-2-amino-4-permissibly-substituted-6-loweralkyl or allyl octahydropyrimido[4,5-g]quinoline or a pharmaceutically-acceptable acid addition salt thereof.
    Type: Grant
    Filed: September 26, 1983
    Date of Patent: June 4, 1985
    Assignee: Eli Lilly and Company
    Inventor: Mark M. Foreman
  • Patent number: 4521598
    Abstract: 7.beta.-Acylamino-3-azido-3-cephem-4-carboxylic acid esters are obtained with the corresponding 3-halo or 3-sulfonyloxy-3-cephem esters and an alkali metal azide. The 3-azido compounds as the free acids or salts are antibacterial agents while in esterified form react with alcohols and phenols to provide 2-alkoxy (or 2-phenoxy)-3amino-3-cephem esters and isomeric ring expanded 4,7-bicyclo .beta.-lactam compounds, namely [2R-(2.alpha.,7.alpha.,8.beta.)-4-alkoxy (or 4-phenoxy)-9-oxo-8-acylamino-6-thia-1,3-diazabicyclo[5.2.0]non-3-ene-2-car boxylic acids and esters and the corresponding 3-alkoxy (or 3-phenoxy) 1,4-diazabicyclo[5.2.0]non-3-ene-2-carboxylic acids and esters. These reaction products obtained with the azide possess antibacterial properties.
    Type: Grant
    Filed: September 28, 1983
    Date of Patent: June 4, 1985
    Assignee: Eli Lilly and Company
    Inventors: Douglas O. Spry, Wayne A. Spitzer
  • Patent number: 4520024
    Abstract: 1-(1-naphthyl)piperazine, a powerful and selective peripheral vascular serotonergic receptor blocker.
    Type: Grant
    Filed: February 11, 1983
    Date of Patent: May 28, 1985
    Assignee: Eli Lilly and Company
    Inventor: Marlene L. Cohen
  • Patent number: 4518531
    Abstract: This invention provides a novel allylic chlorination process for inserting a chlorine atom on the saturated methyl group of a 3-methyl-2-but-3-enoate group on the ring nitrogen atom of a 2-azetidinone or thiazolinoazetidinone. The chloro-substituted compounds prepared thereby are novel intermediates used in preparation of cephalosporins.
    Type: Grant
    Filed: November 14, 1983
    Date of Patent: May 21, 1985
    Assignee: Eli Lilly and Company
    Inventor: Robin D. G. Cooper
  • Patent number: 4515625
    Abstract: N-Aryl benzamides wherein the aryl group is a nitrogen containing heterocycle are useful as selective herbicidal agents. Compositions containing the novel benzamides and a herbicidal method of selective weed control are disclosed.
    Type: Grant
    Filed: July 5, 1983
    Date of Patent: May 7, 1985
    Assignee: Eli Lilly and Company
    Inventor: Kenneth W. Burow, Jr.
  • Patent number: 4515719
    Abstract: 3-Exomethylene cepham sulfones are converted to azetidinone sulfinic acids by reaction with activated zinc, magnesium, activated magnesium or amalgamated magnesium and a protonic acid.
    Type: Grant
    Filed: July 22, 1983
    Date of Patent: May 7, 1985
    Assignee: Eli Lilly and Company
    Inventor: Lawrence J. McShane
  • Patent number: 4515796
    Abstract: This invention provides for certain naphthalenylimidazo compounds, their pharmaceutical formulations, and their use as positive inotropic agents, bronchodilators, vasodilators, and anticoagulants.
    Type: Grant
    Filed: September 8, 1983
    Date of Patent: May 7, 1985
    Assignee: Eli Lilly and Company
    Inventor: David W. Robertson
  • Patent number: 4514564
    Abstract: 7.beta.-[2'-Triazepinone-2'-(oxime ether) acetamido] cephalosporin antibiotics are claimed. Also claimed are the 2'-triazepinone-2'-(oxime ether) acetic acid intermediates and the esters, salts and halides thereof.
    Type: Grant
    Filed: April 18, 1983
    Date of Patent: April 30, 1985
    Assignee: Eli Lilly and Company
    Inventor: William J. Wheeler
  • Patent number: 4513085
    Abstract: The present invention discloses functionally independent selectable recombinant DNA cloning vectors for use in Streptomyces.
    Type: Grant
    Filed: October 7, 1982
    Date of Patent: April 23, 1985
    Assignee: Eli Lilly and Company
    Inventors: Walter M. Nakatsukasa, James A. Mabe
  • Patent number: 4513005
    Abstract: There are described pharmacologically active compounds, useful in the treatment of allergic/inflammatory disorders involving SRS-A as causal mediator and which, in free acid form, are of formula I, ##STR1## in which R.sub.1 is (i) an aliphatic, saturated or unsaturated hydrocarbyl radical of up to 20 carbon atoms, unsubstituted or substituted by at least one substituent selected from halogen, hydroxy, C.sub.3-6 alkoxy, C.sub.3-6 cycloalkyl, aryl or heteroaryl, the cycloalkyl, aryl or heteroaryl being unsubstituted or substituted by at least one substituent selected from hydroxy, halogen and alkyl, alkenyl or alkynyl of up to 10 carbon atoms,(ii) cycloalkyl of 3 to 8 carbon atoms unsubstituted or substituted by alkyl, alkenyl or alkynyl of up to 16 carbon atoms, or(iii) aryl or heteroaryl, unsubstituted or substituted by hydroxyl, C.sub.1-4 alkoxy, halogen or alkyl, alkenyl or alkynyl of up to 16 carbon atoms; and R.sub.
    Type: Grant
    Filed: June 9, 1982
    Date of Patent: April 23, 1985
    Assignee: Lilly Industries Limited
    Inventors: Stephen R. Baker, William B. Jamieson, William J. Ross, Alec Todd
  • Patent number: 4513135
    Abstract: This invention relates to certain amino-5,6-diarylpyrazines useful as activators of GABA and benzodiazepine binding.
    Type: Grant
    Filed: March 5, 1982
    Date of Patent: April 23, 1985
    Assignee: Eli Lilly and Company
    Inventors: David T. Wong, William B. Lacefield
  • Patent number: 4513086
    Abstract: The present invention discloses selectable recombinant DNA cloning vectors for use in Streptomyces and related organisms.
    Type: Grant
    Filed: August 2, 1982
    Date of Patent: April 23, 1985
    Assignee: Eli Lilly and Company
    Inventors: Jeffrey T. Fayerman, Mark A. Richardson
  • Patent number: 4510082
    Abstract: Compounds of the formula ##STR1## and pharmaceutically acceptable non-toxic acid addition salts thereof, in whichR is hydrogen, methyl, ethyl, cyclopropylmethyl, or allyl;A is a residue of a D-amino acid selected from the goup consisting of Ala, Abu, Nva, Val, Nle, Leu, Ile, Gly(Al), Gly(Cp) Met, Cys(Me), Met(O), Cys(Me) (O), Ser, Ser(Me), Thr, and Hse;R.sub.1 is hydrogen, C.sub.1 -C.sub.3 primary alkyl, cyclopropylmethyl, allyl, ethylthiomethyl, 2-fluoroethyl, or propargyl; andX is hydrogen, fluoro, bromo, iodo, chloro, hydroxy, C.sub.1 -C.sub.3 alkyl, trifluoromethyl, or C.sub.1 -C.sub.2 alkoxy; are useful analgesic agents.
    Type: Grant
    Filed: March 7, 1983
    Date of Patent: April 9, 1985
    Assignee: Eli Lilly and Company
    Inventors: Paul D. Gesellchen, Robert T. Shuman
  • Patent number: 4508735
    Abstract: 9-(N-alkanoylaminoalkyl)-fluorenes are anti-arrhythmic agents.
    Type: Grant
    Filed: September 21, 1983
    Date of Patent: April 2, 1985
    Assignee: Eli Lilly and Company
    Inventors: William B. Lacefield, Terry D. Lindstrom